期刊
DIABETOLOGIA
卷 51, 期 2, 页码 336-346出版社
SPRINGER
DOI: 10.1007/s00125-007-0861-3
关键词
immune system; insulin resistance; lipids; Toll-like receptor; NF kappa B; skeletal muscle
资金
- NIDDK NIH HHS [R01 DK058855, T32-DK07052] Funding Source: Medline
Aims/hypothesis A role for increased activity of the innate immune system in the pathogenesis of insulin resistance is supported by a number of studies. The current study assessed the potential role of the lipopolysaccharide receptor known as Toll-like receptor-4 (TLR-4), a component of the innate immune system, in mediating lipid-induced insulin resistance in skeletal muscle. Methods The effects of TLR-4 inhibition/deletion on lipid-induced insulin resistance was determined in skeletal muscle of TLR-4 null mice in vivo and in rat L6 myotubes in vitro. Results In mice, acute hyperlipidaemia induced skeletal muscle insulin resistance, but a deletion of TLR-4 conferred significant protection against these effects. In L6 myotubes, inhibition of TLR-4 activity substantially reduced the capacity of the saturated fatty acid palmitate to induce insulin resistance. Importantly, palmitate activated the nuclear factor kappa B (NF kappa B) pathway in L6 myotubes and mouse skeletal muscle, and these effects were blocked by inhibition of TLR-4 in L6 myotubes and absence of TLR-4 in skeletal muscle. Furthermore, inhibition of the NF kappa B pathway downstream of TLR-4 in L6 myotubes also protected against the induction of insulin resistance by palmitate. Conclusions/interpretation Inhibition or absence of TLR-4 confers protection against the detrimental effects of lipids on skeletal muscle insulin action, and these effects are associated with a prevention of the activation of the NF kappa B pathway by lipids. Importantly, inhibition of the NF kappa B pathway in myotubes downstream of TLR-4 also protects against lipid-induced insulin resistance, suggesting a mechanism by which reduced TLR-4 activity confers beneficial effects on insulin action.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据